Reviva Pharmaceuticals Holdings, Inc. Stock Issued During Period, Shares, Issued for Services
Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Stock Issued During Period, Shares, Issued for Services of 11.00 thousand shares for the 1-month period ending 2021-11-30, per its 10-K filed 2022-03-15.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesIssuedForServices · last filed 2022-03-15
- 2021-11-30: Stock Issued During Period, Shares, Issued for Services 1 month 11.00K shares.
| Period end | Stock Issued During Period, Shares, Issued for Services 1 month |
|---|---|
| 2021-11-30 | 11.00K shares 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |